tirzepatide higher dose trial Doses of Zepbound and Mounjaro Being Tested Tirzepatide Outperforms Dulaglutide on Cardiorenal

Plateaus lasting 1-3 weeks are normal and don't indicate treatment failure

This increased vascularization delivers more oxygen and nutrients to damaged tissues, accelerating the healing process

The bottom line is these medications should be $200-$300 a month, not $1300

Beyond Glucagon-like Peptide-1: is G-Protein coupled receptor polypharmacology the path forward to treating metabolic diseases

Patients have reported vision loss and damage to the optic nerve, including rare conditions like non-arteritic anterior ischemic optic neuropathy (NAION) and arteritic anterior ischemic optic neuropathy

CrossRef Data Analysis and Accuracy Evaluation of a Continuous Glucose-Monitoring Device Lijun Cai, Wancheng Ge, Zhigang Zhu, Xueling Zhao, Zhanhong Li Journal of Sensors.2019